METTL3 and atherosclerosis: Moreover, miR-1208 can inhibit the expression of NLRP3 and lead to decreased release of inflammatory cytokines after targeted binding to METTL3, suggesting that miR-1208 and its downstream gene METTL3 are potential targets for the prevention and treatment of atherosclerosis (Zhou et al. 2022a, b).